Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III

NCT03117036 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Hodgkin

Interventions

DRUG: Chemotherapy

Sponsor

Samsung Medical Center

Collaborators

[object Object]